Health Blueprint

Back to Longevity News

News summary

Likang Life Sciences Showcases Personalized Cancer Immunotherapy and Global Ambitions at Abu Dhabi Future Health Summit 2026

Source: PR Newswire • Published: 24 Oct 2026, 11:27

Summarized by Masters of Longevity from PR Newswire.

Report on a biotech company's presentation of AI-enabled personalized cancer immunotherapy and expansion plans discussed at an international health summit.

Likang Life Sciences Showcases Personalized Cancer Immunotherapy and Global Ambitions at Abu Dhabi Future Health Summit 2026
Key Takeaways
  • Cheung spoke on "The Future of Cancer," moderated by Dr.
  • Likang Life Sciences is a biotechnology company focused on AI-powered personalized cancer immunotherapy.
  • Its pipeline includes personalized neoantigen therapeutic vaccines and neoantigen-specific T-cell therapies.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickFrom Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.